{
    "code": "10000920",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000920",
    "time": "2017-06-16 03:04:39",
    "許可證字號": "衛署菌疫輸字第000920號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/12\/05",
    "發證日期": "100\/12\/05",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000092002",
    "中文品名": "喜達諾 TM 注射液",
    "英文品名": "Stelara TM Solution for Injection",
    "適應症": "1. 乾癬(Ps)\r\nSTELARA適用於治療適合接受光療法或全身性治療的\r\n中至重度斑塊性乾癬成人患者(18歲(含)以上)。\r\n兒童乾癬(Pediatric Psoriasis) STELARA適用於治療對光療法或\r\n其他全身性治療無法有效控制或無法耐受之中至重度斑塊性乾癬青少年患者(12歲(含)以上)。\r\n2. 乾癬性關節炎(PsA)\r\nSTELARA適用於治療對疾病緩解型抗風濕性藥物(DMARDs)療效不佳\r\n之成人(18歲及以上)活動性乾癬性關節炎。\r\nSTELARA可單獨使用，亦可與methotrexate (MTX)併用。\r\nSTELARA可單獨使用，亦可與methotrexate (MTX)併用，\r\n可以減緩疾病造成的關節結構性受損。",
    "劑型": "230預充填式注射劑",
    "包裝": "45毫克\/0.5毫升玻璃預充填注射針筒裝 90毫克\/1.0毫升玻璃預充填注射針筒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "Ustekinumab"
    ],
    "限制項目": "02輸　入 1D須執行風險管理計畫 51免除銜接性臨床試驗",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M461120000  BAXTER PHARMACEUTICAL SOLUTIONS LLC",
        "製造廠廠址": "927 SOUTH CURRY PIKE, BLOOMINGTON, INDIANA 47403, USA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F170059000  JANSSEN BIOLOGICS B.V.",
            "製造廠廠址": "EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDS",
            "製造廠公司地址": "EINSTEINWEG 92, 2333 CD LEIDEN, THE NETHERLANDS",
            "製造廠國別": "NETHERLANDS",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "F230080000  JANSSEN SCIENCES IRELAND UC",
            "製造廠廠址": "BARNAHELY, RINGASKIDDY, CO.CORK, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "F430263000  CILAG AG",
            "製造廠廠址": "HOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "二級包裝、批次放行"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002700",
            "成分名稱": "Ustekinumab",
            "含量描述": "",
            "含量": "45.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版]0511-35757B-Baxter-106-05-15(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000920&Seq=014&Type=9"
        },
        {
            "title": "PI_Stelara_Baxter_USPIMar2014+EUPI22Jun2015_v1601(Chn)-105-07-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000920&Seq=013&Type=9"
        },
        {
            "title": "喜達諾 注射液 中文小標籤-106-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000920&Seq=004&Type=8"
        },
        {
            "title": "喜達諾 注射液 label-106-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000920&Seq=003&Type=8"
        },
        {
            "title": "喜達諾 注射液 box-106-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000920&Seq=002&Type=8"
        }
    ]
}